A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-1200 in Participants with Advanced Solid Tumors (NCT06242691)
MK-1200-002
This trial is No longer recruiting
Registration number NCT06242691
Program & service
This trial is being run with the Cancer service, and as part of the Medical Oncology program.
Trial phase
Phase 1
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Sanjeev Gill
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR